Minako Oshima

932 total citations
53 papers, 793 citations indexed

About

Minako Oshima is a scholar working on Neurology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Minako Oshima has authored 53 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Neurology, 19 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Molecular Biology. Recurrent topics in Minako Oshima's work include Myasthenia Gravis and Thymoma (20 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Minako Oshima is often cited by papers focused on Myasthenia Gravis and Thymoma (20 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Botulinum Toxin and Related Neurological Disorders (14 papers). Minako Oshima collaborates with scholars based in United States, Japan and Australia. Minako Oshima's co-authors include M. Zouhair Atassi, Philip R. Deitiker, Tetsuo Ashizawa, John L. Middlebrook, Dennis R. Mosier, Mohan Shenoy, Premkumar Christadoss, Marilyn S. Pollack, Makoto Hayakari and Joseph Jankovic and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and European Journal of Immunology.

In The Last Decade

Minako Oshima

53 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minako Oshima United States	15	600	203	148	146	135	53	793
T. Barkas Switzerland	14	350 0.6×	43 0.2×	75 0.5×	264 1.8×	292 2.2×	34	761
Masaru Kitamura Japan	14	466 0.8×	200 1.0×	59 0.4×	19 0.1×	166 1.2×	28	710
Brenda Diethelm‐Okita United States	15	85 0.1×	40 0.2×	42 0.3×	206 1.4×	317 2.3×	22	898
Guang Ping Gao United States	12	62 0.1×	61 0.3×	167 1.1×	192 1.3×	869 6.4×	15	1.3k
Vanda Lux Germany	10	142 0.2×	27 0.1×	76 0.5×	43 0.3×	343 2.5×	15	735
Céline Monnet France	15	42 0.1×	71 0.3×	41 0.3×	204 1.4×	389 2.9×	18	646
Pei M. Aui Australia	11	51 0.1×	80 0.4×	182 1.2×	22 0.2×	77 0.6×	17	521
P. Krueger United States	13	36 0.1×	59 0.3×	71 0.5×	93 0.6×	142 1.1×	25	846
Micaela Pelagi Italy	16	43 0.1×	90 0.4×	21 0.1×	107 0.7×	221 1.6×	22	485
Bonnie Landmeier United States	9	238 0.4×	8 0.0×	51 0.3×	217 1.5×	217 1.6×	11	593

Countries citing papers authored by Minako Oshima

Since Specialization

Citations

This map shows the geographic impact of Minako Oshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minako Oshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minako Oshima more than expected).

Fields of papers citing papers by Minako Oshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minako Oshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minako Oshima. The network helps show where Minako Oshima may publish in the future.

Co-authorship network of co-authors of Minako Oshima

This figure shows the co-authorship network connecting the top 25 collaborators of Minako Oshima. A scholar is included among the top collaborators of Minako Oshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minako Oshima. Minako Oshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oshima, Minako, Philip R. Deitiker, Tandy Hastings‐Ison, et al.. (2017). Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules. Journal of Neuroimmunology. 306. 31–39. 11 indexed citations

Deitiker, Philip R., Minako Oshima, Joseph Jankovic, & M. Zouhair Atassi. (2017). Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule. Immunology Letters. 190. 257–264. 3 indexed citations

Oshima, Minako, Philip R. Deitiker, Joseph Jankovic, K. Roger Aoki, & M. Zouhair Atassi. (2015). Submolecular recognition of the C-terminal domain of the heavy chain of botulinum neurotoxin type A by T cells from toxin-treated cervical dystonia patients. Immunobiology. 221(4). 568–576. 5 indexed citations

Atassi, M. Zouhair, Minako Oshima, Behzod Z. Dolimbek, & K. Roger Aoki. (2011). Antibody and T cell recognition of the light chain of botulinum neurotoxin A in two high-responder mouse strains. Immunobiology. 217(1). 1–7. 8 indexed citations

Oshima, Minako, et al.. (2011). T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients. Autoimmunity. 45(2). 153–160. 7 indexed citations

Deitiker, Philip R., Minako Oshima, Joseph Jankovic, et al.. (2010). Association of HLA Class II alleles and haplotypes with cervical dystonia: HLA DR13-DQ6 (DQB1*0604) homozygotes are at greatly increased risk of cervical dystonia in Caucasian Americans. Autoimmunity. 44(3). 167–176. 11 indexed citations

Deitiker, Philip R., et al.. (2010). Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States. International Journal of Immunogenetics. 38(1). 55–62. 18 indexed citations

Oshima, Minako, Philip R. Deitiker, & M. Zouhair Atassi. (2007). Targeting the Antigen-Binding Site of HLA-Restricting Alleles in Treatment of Autoimmune Disease. Critical Reviews in Immunology. 27(3). 271–288. 5 indexed citations

Deitiker, Philip R., Minako Oshima, Richard Smith, Dennis R. Mosier, & M. Zouhair Atassi. (2006). Subtle differences in HLA DQ haplotype-associated presentation of AChR α-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 39(4). 277–288. 14 indexed citations

10.

Maruta, Takahiro, Minako Oshima, Philip R. Deitiker, Maki Ohtani, & M. Zouhair Atassi. (2006). Use of Alum and InactiveBordetella pertussisfor Generation of Antibodies Against Synthetic Peptides in Mice. Immunological Investigations. 35(2). 137–148. 3 indexed citations

11.

Oshima, Minako, Maki Ohtani, Philip R. Deitiker, et al.. (2005). Suppression by mAbs against DQB1 peptides ofin vitroproliferation of AChR-specific T cells from myasthenia gravis patients. Autoimmunity. 38(2). 161–169. 8 indexed citations

12.

Oshima, Minako, et al.. (2005). Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. Journal of Neuroimmunology. 171(1-2). 8–16. 6 indexed citations

13.

Oshima, Minako, et al.. (2000). Suppression of experimental myasthenia gravis by monoclonal antibodies against MHC peptide region involved in presentation of a pathogenic T-cell epitope. Journal of Neuroimmunology. 105(2). 131–144. 9 indexed citations

14.

Oshima, Minako, John L. Middlebrook, & M. Zouhair Atassi. (1998). Antibodies and T cells against synthetic peptides of the C-terminal domain (Hc) of botulinum neurotoxin type A and their cross-reaction with Hc. Immunology Letters. 60(1). 7–12. 22 indexed citations

15.

Oshima, Minako, Makoto Hayakari, John L. Middlebrook, & M. Zouhair Atassi. (1997). Immune recognition of botulinum neurotoxin type A: Regions recognized by T cells and antibodies against the protective HC fragment (residues 855–1296) of the toxin. Molecular Immunology. 34(14). 1031–1040. 23 indexed citations

16.

Oshima, Minako, Andrew R. Pachner, & M. Zouhair Atassi. (1994). Profile of the regions of acetylcholine receptor α chain recognized by T-lymphocytes and by antibodies in eamg-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor. Molecular Immunology. 31(11). 833–843. 21 indexed citations

17.

Christadoss, Premkumar, Mohan Shenoy, Minako Oshima, & M. Zouhair Atassi. (1994). Suppression of Experimental Autoimmune Myasthenia Gravis by Epitope-Specific Neonatal Tolerance. Advances in experimental medicine and biology. 347. 65–75. 3 indexed citations

18.

Shenoy, Mohan, Minako Oshima, M. Zouhair Atassi, & Premkumar Christadoss. (1993). Suppression of Experimental Autoimmune Myasthenia Gravis by Epitope-Specific Neonatal Tolerance to Synthetic Region α146-162 of Acetylcholine Receptor. Clinical Immunology and Immunopathology. 66(3). 230–238. 64 indexed citations

19.

Oshima, Minako, Tetsuo Ashizawa, Marilyn S. Pollack, & M. Zouhair Atassi. (1990). Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the α subunit. European Journal of Immunology. 20(12). 2563–2569. 60 indexed citations

20.

Oshima, Minako & M. Zouhair Atassi. (1989). Comparison of Peptide-Coating Conditions in Solid Phase Plate Assays for Detection of Anti-Peptide Antibodies. Immunological Investigations. 18(7). 841–851. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact